Aston University Develops Quick Prostate Cancer Test

Researchers at Aston University have developed a groundbreaking 15-minute blood test that can detect prostate cancer with up to 90% accuracy before symptoms appear, using a technique that analyzes the 3D shape changes of blood proteins. The study, published in the journal Scientific Reports, involved 108 dried blood samples and highlights the test's potential to significantly improve early diagnosis, which is crucial since prostate cancer accounts for nearly 10% of cancer deaths in men. The non-invasive nature of this test contrasts sharply with current methods, which often involve uncomfortable biopsies and rectal exams. Experts express excitement over the test's implications for personalized medicine but caution that further research is necessary to confirm its effectiveness. Meanwhile, a separate study from Flinders University and the University of South Australia is exploring a new drug, CDKI-73, which targets CDK9 protein to combat aggressive prostate cancer types. As these advancements unfold, the need for improved screening and treatment options in prostate cancer becomes increasingly apparent.